Can you add peptides to testosterone therapy?
In many cases, yes, because they work on different systems. Testosterone therapy replaces a hormone your body is not making enough of. Growth hormone peptides work upstream: the tesamorelin label describes it as a synthetic version of growth hormone-releasing factor that prompts the pituitary to release your own growth hormone, which in turn raises IGF-1. Sermorelin, once FDA-approved as Geref and now compounded, works through the same pathway.
So a peptide is not a substitute for TRT, and TRT does not do what a growth hormone peptide does. Combining them only makes sense when there is a specific goal the testosterone plan is not reaching, such as stubborn visceral fat or a slow recovery, and when labs support it. Our comparison of sermorelin and TRT explains how the two differ.
Which peptides come up alongside TRT?
Each peptide has a different status and a different reason to be considered. As of October 2026:
| Peptide | What it targets | FDA status | Extra monitoring |
|---|---|---|---|
| Sermorelin | Growth hormone release | Compounded by licensed pharmacies | IGF-1, glucose |
| Tesamorelin | Growth hormone release; abdominal fat | FDA-approved (Egrifta) for HIV-associated abdominal fat; other use is off-label | IGF-1, glucose and A1C |
| BPC-157, TB-500, Wolverine stack | Recovery from injury | Off the FDA safety-concern list since April 2026; no final rule, availability unsettled | Depends on what is available |
| GHK-Cu | Skin and tissue repair | FDA review due by early 2027 | Depends on what is available |
| NAD+ | Cellular energy | Widely available as an injection and IV | Set by your provider |
BPC-157 and TB-500 are also on the World Anti-Doping Agency prohibited list, which matters if you compete in tested sport.
Which labs get added to your monitoring?
Your testosterone labs stay the same; the peptide adds its own. Your provider follows testosterone, estradiol, PSA and a complete blood count as part of TRT, and our page on how often blood work is needed on TRT covers that schedule. A growth hormone peptide adds:
- IGF-1. Because growth hormone pulses up and down through the day, MedlinePlus notes that IGF-1 is the steadier marker for tracking it. A baseline before the first dose and a recheck afterward show whether the peptide is working and whether you have overshot. The tesamorelin label reports that 47 percent of trial patients had IGF-1 more than 2 standard deviation scores above the mean by 26 weeks, and it advises considering stopping if levels stay very high.
- Fasting glucose and A1C. Growth hormone can make the body less sensitive to insulin; the somatropin label warns it may decrease insulin sensitivity, especially at higher doses. The tesamorelin label asks clinicians to check glucose before starting and periodically after, and in its trials 5 percent of patients on the drug reached a diabetes-range A1C, against 1 percent on placebo.
Our page on IGF-1 on sermorelin or tesamorelin explains how results are read, and the HbA1c test page covers the blood sugar side.
Do fluid retention and blood pressure need closer watching?
They deserve attention, because each treatment brings its own reason to watch. The tesamorelin label describes fluid retention linked to rising growth hormone, showing up as swelling, joint aches or carpal tunnel symptoms, which it says are usually temporary or resolve when treatment stops.
On the testosterone side, the FDA’s 2025 class-wide labeling changes added blood pressure warnings to testosterone products. Adding a growth hormone peptide does not change that warning, but swelling, a weight jump from fluid or a rise in home blood pressure readings is worth reporting rather than waiting for the next scheduled visit.
Can a peptide replace TRT if you would rather stop?
Not directly. A growth hormone peptide does not raise testosterone, so stopping TRT and switching to sermorelin would leave the original problem untreated. Our answer on whether peptides can raise testosterone goes into the options for men who want to protect their own production.
How Ultimate Male layers peptides onto a TRT plan
If you are already in our testosterone therapy program, your provider starts with your current labs and adds IGF-1, glucose and metabolic markers before a peptide is considered. A one-on-one consultation decides whether a peptide fits your goal, and which one; it is an evaluation, not a promise of treatment.
If a peptide is added through our peptide therapy program, the first injection is shown in clinic, and follow-up labs and a check-in come at six to eight weeks. Draws for both treatments happen on site at San Gabriel or Downey. Start with the free 10-minute call if you want to talk through whether adding one makes sense.

